NIR in Cerebrum

NeuroPerspective’s editor and publisher, Harry Tracy PhD, was invited to provide a current assessment of the funding environment for therapeutics programs in the areas of Neurology/Psychiatry by Cerebrum, published by the Dana Foundation. That article–The Neuro Funding Rollercoaster–was released in early June. The link to the online publication, and the associated podcast,is: http://www.dana.org/Cerebrum/2016/The_Neuro_Funding_Rollercoaster.

This entry was posted in Biotech. Bookmark the permalink.

One Response to NIR in Cerebrum

  1. Leo Liu says:

    Harry, this is an EXCELLENT review, thanks. Did you track the numerator of how much $$ has flowed into VC overall? I wonder if part of the recent rise in CNS investments is due to too much $$ chasing too few opportunities (e.g. the precision oncology space is saturated).

    Also, what do you think of the idea from Tanzi et al that AD has an infectious/post-infectious immune response etiology? This wouldn’t be the first chronic disease discovered to have such a basis (PUD, cervical CA, etc). There’s a bizarre CNS disease in African children called Nodding Syndrome (looks like kuru when you see them on video) that is increasingly being tied to Onchocerca (river blindness) infection…

    Leo

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s